160 related articles for article (PubMed ID: 22702638)
1. Impact of regulatory guidances and drug regulation on risk minimization interventions in drug safety: a systematic review.
Nkeng L; Cloutier AM; Craig C; Lelorier J; Moride Y
Drug Saf; 2012 Jul; 35(7):535-46. PubMed ID: 22702638
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. Safety-related regulatory actions for orphan drugs in the US and EU: a cohort study.
Heemstra HE; Giezen TJ; Mantel-Teeuwisse AK; de Vrueh RL; Leufkens HG
Drug Saf; 2010 Feb; 33(2):127-37. PubMed ID: 20082539
[TBL] [Abstract][Full Text] [Related]
4. Methodological gaps in the assessment of risk minimization interventions: a systematic review.
Gridchyna I; Cloutier AM; Nkeng L; Craig C; Frise S; Moride Y
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):572-9. PubMed ID: 24616240
[TBL] [Abstract][Full Text] [Related]
5. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016.
Perry LT; Bhasale A; Fabbri A; Lexchin J; Puil L; Joarder M; Mintzes B
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1054-1063. PubMed ID: 32696556
[TBL] [Abstract][Full Text] [Related]
6. Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories.
Boyd IW; McEwen J
Drug Saf; 2023 Jul; 46(7):703-710. PubMed ID: 37266905
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
[TBL] [Abstract][Full Text] [Related]
9. Impact of safety-related regulatory action on clinical practice: a systematic review.
Piening S; Haaijer-Ruskamp FM; de Vries JT; van der Elst ME; de Graeff PA; Straus SM; Mol PG
Drug Saf; 2012 May; 35(5):373-85. PubMed ID: 22480319
[TBL] [Abstract][Full Text] [Related]
10. European Medicines Agency assesses safety reporting at Roche.
Marshall H
Lancet Oncol; 2012 Aug; 13(8):e331. PubMed ID: 23024993
[No Abstract] [Full Text] [Related]
11. The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.
Dias P; Penedones A; Alves C; Ribeiro CF; Marques FB
Curr Drug Saf; 2015; 10(3):234-50. PubMed ID: 26219291
[TBL] [Abstract][Full Text] [Related]
12. Risk minimization activities of centrally authorized products in the EU: a descriptive study.
Zomerdijk IM; Sayed-Tabatabaei FA; Trifirò G; Blackburn SC; Sturkenboom MC; Straus SM
Drug Saf; 2012 Apr; 35(4):299-314. PubMed ID: 22339506
[TBL] [Abstract][Full Text] [Related]
13. Review of FDA Amendments Act Section 921 Experience in Posting Data-mining Results from the FAERS Database.
Beninger P; Murray M
Clin Ther; 2021 Feb; 43(2):380-395. PubMed ID: 33504449
[TBL] [Abstract][Full Text] [Related]
14. Provision of information on regulatory authorities' websites.
Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
[TBL] [Abstract][Full Text] [Related]
15. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
16. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.
Banerjee AK; Okun S; Edwards IR; Wicks P; Smith MY; Mayall SJ; Flamion B; Cleeland C; Basch E;
Drug Saf; 2013 Dec; 36(12):1129-49. PubMed ID: 24092596
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period.
Yaju Y; Kataoka Y; Eto H; Horiuchi S; Mori R
Cochrane Database Syst Rev; 2013 Nov; (11):CD009328. PubMed ID: 24277681
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
